Dr. Michelle Berny-Lang serves as a Program Director in the Center for Strategic Scientific Initiatives (CSSI) at the NCI. In this capacity, she participates in the organization, development, and evaluation of CSSI initiatives, working to facilitate multidisciplinary collaborations among researchers, NCI and NIH colleagues, and external partners.
With the National Institute of Biomedical Imaging and Bioengineering (NIBIB), she coordinates a program in Synthetic Biology and Cancer to bring innovative technology approaches to challenges in cancer research. She is NCI’s lead for the Big Data Scientist Training Enhancement Program (BD-STEP), a collaboration with the Department of Veterans Affairs (VA), which immerses data science fellows into the VA healthcare system to advance research and patient care. Within NCI, she co-chairs the trans-NCI Advisory Committee to CSSI (TACTIC).
Before joining the NCI, Dr. Berny-Lang was a postdoctoral fellow at Harvard Medical School, Boston Children’s Hospital, investigating novel cellular pathways in clinical disorders such as acute coronary syndrome and sickle cell disease. She received her Ph.D. in biomedical engineering from Oregon Health & Science University, with research focused on mechanisms of thrombosis. She holds a bachelor’s degree in bioengineering from Oregon State University.